As average ozone exposure in the first 2 years of life rose, so did the likelihood for caregiver-reported asthma and wheeze ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in ...

An award-winning pathologist who devoted his life to melanoma research became the first person to receive a novel ...

Oncology practices must address barriers related to technology and workflow to successfully implement a system to collect patient-reported outcomes, according to a viewpoint paper published in JAMA ...

As we move forward into a new era of ophthalmology, with increased options to address vision issues, patient expectations are ...

Living along coastal areas in the United States that had higher levels of microplastics in the ocean was strongly associated ...

The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of ...

Extended depth of focus contact lenses improved near to intermediate vision while maintaining far vision, leading to higher ...

After 37 years as a liver transplant surgeon, and after performing more than 1,000 surgeries, I have come to appreciate the successes and challenges of the U.S. organ donation and transplant system.

The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...

The deportation of immigrant workers and restrictions on immigration could negatively affect health care in the United States ...

Women who reported a greater number of symptoms during perimenopause also reported poorer cognitive function and more mild ...